NASDAQ · KMTS
Healthcare · Medical - Instruments & Supplies
$29.81
Down-$0.80 (-2.68%)
Updated Nov 3, 2026, 10:16 PM
SID Score
5.0/10
Composite research score
Smart Money
—
Institutional and insider signal
Price performance · KMTS
1M range · 21 trading sessions · Daily adjusted prices
Prices through Nov 2, 2026
KMTS closed at $29.81 after 21 trading sessions, up 5.19% for the selected period.
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Nov 2, 2026 | $30.00 | $30.33 | $29.125 | $29.81 | 412.95K |
| Oct 30, 2026 | $30.73 | $31.0575 | $28.77 | $29.69 | 324.92K |
| Oct 29, 2026 | $30.00 | $31.04 | $30.00 | $30.61 | 470.66K |
| Oct 28, 2026 | $29.59 | $31.015 | $29.49 | $29.87 | 538.41K |
| Oct 27, 2026 | $29.78 | $30.4201 | $29.31 | $29.99 | 514.27K |
| Oct 26, 2026 | $28.95 | $29.635 | $28.525 | $29.42 | 294.07K |
| Oct 23, 2026 | $28.09 | $28.93 | $27.96 | $28.76 | 357.21K |
| Oct 22, 2026 | $27.17 | $29.265 | $27.17 | $28.32 | 739.13K |
| Oct 21, 2026 | $27.90 | $28.57 | $26.78 | $27.31 | 689.22K |
| Oct 20, 2026 | $29.75 | $29.94 | $28.22 | $28.28 | 601.26K |
| Oct 19, 2026 | $27.31 | $29.75 | $27.03 | $29.37 | 638.78K |
| Oct 16, 2026 | $28.71 | $29.01 | $26.99 | $27.24 | 521.92K |
| Oct 15, 2026 | $25.68 | $28.78 | $25.66 | $28.68 | 405.48K |
| Oct 14, 2026 | $26.45 | $26.715 | $25.39 | $25.47 | 237.44K |
| Oct 13, 2026 | $27.00 | $27.27 | $26.43 | $26.97 | 131.78K |
| Oct 12, 2026 | $27.02 | $27.20 | $26.2945 | $26.91 | 131.01K |
| Oct 9, 2026 | $25.74 | $27.13 | $25.74 | $26.98 | 246.78K |
| Oct 8, 2026 | $26.17 | $26.175 | $25.25 | $25.77 | 379.73K |
| Oct 7, 2026 | $26.56 | $27.61 | $25.90 | $26.49 | 399.46K |
| Oct 6, 2026 | $28.68 | $29.2384 | $27.06 | $27.10 | 262.26K |
| Oct 5, 2026 | $27.64 | $28.44 | $27.21 | $28.34 | 293.64K |
The latest Smart Investors Daily articles mentioning KMTS.
Company
Market Activity
Research & News
KMTS research
Company profile and research snapshot.
Kestra Medical Technologies Ltd is a commercial-stage, wearable medical device and digital healthcare company focused on transforming patient outcomes in cardiovascular disease using monitoring and therapeutic intervention technologies that are intuitive, intelligent, and connected. It has developed and is commercializing its Cardiac Recovery System platform, a comprehensive and developed system that integrates monitoring, therapeutic treatment, digital health, and patient support services into a single, unified solution. The cornerstone of its Cardiac Recovery System platform is the ASSURE WCD, a next-generation wearable cardioverter defibrillator (WCD) used to protect patients at an elevated risk of sudden cardiac arrest (SCA), a prominent public health problem.
Visit company websiteConsensus and target data currently published for this company.
| Date | Firm | Rating | Target |
|---|---|---|---|
| Oct 20, 2026 | Evercore ISI Group | Outperform | — |
| Sep 15, 2026 | BTIG | Buy | — |
| Sep 2, 2026 | BTIG | Buy | — |
| Aug 10, 2026 | JP Morgan | Overweight | — |
| Jul 21, 2026 | Oppenheimer | Perform | — |
No generated briefing is available yet.
Benzinga · Oct 20, 2026
Evercore ISI Group analyst Vijay Kumar initiates coverage on Kestra Medical Techs (NASDAQ:KMTS) with a Outperform rating and announces Price Target of $34.
Yahoo · Oct 1, 2026
KIRKLAND, Wash., Oct. 01, 2026 (GLOBE NEWSWIRE) -- Kestra Medical Technologies, Ltd. (Nasdaq: KMTS), a leading wearable medical device and digital healthcare company, has earned a five-star rating on Newsweek’s list of America’s Greatest Mid-Market Companies 2026. Only 30 of the 100 honorees earned five stars, and Kestra was the only company in the Medical Equipment Manufacturing category to receive that rating. “In less than a decade, our team brought the ASSURE® WCD to market and built a rapid
Yahoo · Sep 22, 2026
Why Kestra Medical Technologies Stock Is Back In Focus Kestra Medical Technologies (KMTS) has drawn fresh attention after first quarter results showed sales of US$30.97 million and a net loss of US$44.09 million, alongside a higher fiscal 2027 revenue outlook. The recent update has landed after a strong run in Kestra Medical Technologies’ share price, with a 90 day share price return of 19.72%. This comes even though the 30 day share price return is down 8.23% and the 1 year total shareholder...
Yahoo · Sep 17, 2026
Kestra Medical Technologies, Ltd. (NASDAQ:KMTS) reported on September 14 that fiscal first-quarter 2027 revenue increased 60% to $31.0 million. Gross margin reached 56.5%, up from 45.7%, for the quarter ended July 31, 2026. Management raised fiscal 2027 revenue guidance to $141 million from $137 million, implying 48% annual growth. The outlook strengthens the commercial story, […]
Interpretive context generated from the platform’s current data sources.
No results
AI research layers have not been published yet.
The latest Smart Investors Daily articles mentioning KMTS.
